Highly concentrated vascular endothelial growth factor in platelets in Crow-Fukase syndrome.

T Hashiguchi, K Arimura, K Matsumuro, R Otsuka, O Watanabe, M Jonosono, Y Maruyama, I Maruyama, M Osame

Journal: Muscle & nerve 2000;23(7):1051-6

PMID: 10882999

Abstract

We report a marked difference in concentration of vascular endothelial growth factor (VEGF) between serum and plasma in patients with Crow-Fukase syndrome (CFS). The serum/plasma VEGF levels in 4 CFS patients were 8,634/152, 5,203/176, 3,724/127, and 868/13 pg/ml, respectively. We also showed that platelets were a major source of this VEGF and that VEGF was released during platelet aggregation by physiological stimulation. It is suggested that in CFS, local VEGF concentration is markedly elevated by aggregation of platelets containing excessive VEGF and their adhesion to vascular walls, resulting in excessive physiological activities of VEGF. Our findings provide important information for developing more effective therapeutic trials.

Address: Third Department of Internal Medicine, Kagoshima University, School of Medicine, 8-35-1 Sakuragaoka, Kagoshima, 890-8520 Japan. [email protected]

DOI: 10.1002/1097-4598(200007)23:7<1051::aid-mus7>3.0.co;2-v

Link outs

Subscription / membership required

Full Text Sources:

https://doi.org/10.1002/1097-4598(200007)23:7<1051...

MeSH Terms: Adenosine Diphosphate, Aged, Anti-Inflammatory Agents, Blood Platelets, Calcium, Endothelial Growth Factors, Enzyme-Linked Immunosorbent Assay, Female, Humans, Lymphokines, Male, Methylprednisolone, Middle Aged, POEMS Syndrome, Platelet Activation, Platelet Aggregation, Platelet Count, Thrombin, Vascular Endothelial Growth Factor A, Vascular Endothelial Growth Factors